BJL
JAZZ icon

Brighton Jones LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

Brighton Jones LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$562K Buy
2,333
+758
+48% +$166K 0.01% 746
2026
Q1 		$298K Buy
+1,575
New +$275K 0.01% 938
2022
Q3 		– Sell
-1,294
Closed -$202K – 489
2022
Q2 		$202K Buy
+1,294
New +$199K 0.01% 427
2021
Q3 		– Sell
-1,323
Closed -$235K – 503
2021
Q2 		$235K Buy
1,323
+3
+0.2% +$520 0.01% 415
2021
Q1 		$217K Buy
1,320
+8
+0.6% +$1.32K 0.01% 386
2020
Q4 		$217K Buy
+1,312
New +$195K 0.01% 353
2020
Q1 		– Sell
-1,409
Closed -$210K – 306
2019
Q4 		$210K Buy
+1,409
New +$192K 0.02% 300
2018
Q4 		– Sell
-1,314
Closed -$221K – 278
2018
Q3 		$221K Sell
1,314
-2
-0.2% -$344 0.03% 253
2018
Q2 		$227K Sell
1,316
-44
-3% -$7.19K 0.03% 269
2018
Q1 		$205K Buy
+1,360
New +$200K 0.03% 273
2017
Q3 		– Sell
-1,368
Closed -$213K – 300
2017
Q2 		$213K Buy
+1,368
New +$209K 0.03% 252
2016
Q3 		– Sell
-1,507
Closed -$213K – 239
2016
Q2 		$213K Sell
1,507
-67
-4% -$9.88K 0.04% 190
2016
Q1 		$205K Sell
1,574
-224
-12% -$27.9K 0.04% 194
2015
Q4 		$253K Buy
+1,798
New +$249K 0.05% 164
2015
Q1 		– Sell
-1,307
Closed -$214K – 195
2014
Q4 		$214K Sell
1,307
-1,410
-52% -$234K 0.05% 179
2014
Q3 		$436K Sell
2,717
-21
-0.8% -$3.23K 0.1% 116
2014
Q2 		$403K Buy
2,738
+7
+0.3% +$971 0.09% 114
2014
Q1 		$379K Hold
2,731
– – 0.09% 115
2013
Q4 		$346K Sell
2,731
-513
-16% -$53.1K 0.08% 123
2013
Q3 		$298K Buy
+3,244
New +$262K 0.08% 115

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Brighton Jones LLC's JAZZ Position: Q2 2026 in Review

Brighton Jones LLC increased its Jazz Pharmaceuticals (JAZZ) stake by 48% in Q2 2026, buying an estimated $166K and bringing the position to 2,333 shares worth $562K. The position accounts for 0.01% of the portfolio, ranked #746.

Brighton Jones LLC first reported a position in JAZZ in Q3 2013 and has held it in 20 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Brighton Jones LLC held 2,333 shares of Jazz Pharmaceuticals worth $562K as of Q2 2026.
  • Brighton Jones LLC bought 758 Jazz Pharmaceuticals shares in Q2 2026, an estimated $166K.
  • Jazz Pharmaceuticals made up 0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #746 holding.
  • Brighton Jones LLC first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 20 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.